Health
World News | Longer Gap in Pfizer-BioNTech COVID Vaccines Boosts Antibody Levels: Study – LatestLY
Get latest articles and stories on World at LatestLY. A longer gap between first and second doses of the Pfizer-BioNTech COVID-19…
London, Jul 24 (PTI) A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with…
Continue Reading
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers